APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ziprasidone Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ziprasidone Drugs Industry Growth and Trends Forecast to 2032

28 December 2025101 pages

Choose your research edition.

Industry ResearchZiprasidone Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ziprasidone Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Ziprasidone Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ziprasidone Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Ziprasidone Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Ziprasidone Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ziprasidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ziprasidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ziprasidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ziprasidone Drugs include Apotex, Aurobindo Pharma, Chartwell, Dr. Reddy's Laboratories, Gland Pharma, Lupin, Viatris, Zydus and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ziprasidone Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ziprasidone Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ziprasidone Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ziprasidone Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ziprasidone Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ziprasidone Drugs Market by Company

Apotex

Aurobindo Pharma

Chartwell

Dr. Reddy's Laboratories

Gland Pharma

Lupin

Viatris

Zydus

Pfizer

Jiangsu Nhwa Pharmaceutical

Sandoz

Chongqing Shenghuaxi Pharmaceutical

Ziprasidone Drugs Segment by Type

Ziprasidone Hydrochloride

Ziprasidone Mesylate

Ziprasidone Drugs Segment by Application

Hospital and Clinic

Pharmacy

Other

Ziprasidone Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ziprasidone Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ziprasidone Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ziprasidone Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ziprasidone Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ziprasidone Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ziprasidone Hydrochloride Table 2. Major Company of Ziprasidone Mesylate Table 3. Global Ziprasidone Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ziprasidone Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Ziprasidone Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ziprasidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ziprasidone Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Ziprasidone Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Ziprasidone Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Ziprasidone Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ziprasidone Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ziprasidone Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Ziprasidone Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Ziprasidone Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Ziprasidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ziprasidone Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Ziprasidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ziprasidone Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Ziprasidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ziprasidone Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Ziprasidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ziprasidone Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Ziprasidone Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Ziprasidone Drugs Industry Trends Table 25. Ziprasidone Drugs Industry Drivers Table 26. Ziprasidone Drugs Industry Opportunities and Challenges Table 27. Ziprasidone Drugs Industry Restraints Table 28. Global Ziprasidone Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ziprasidone Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Ziprasidone Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Ziprasidone Drugs Sales Share by Company (2021-2026) Table 32. Global Ziprasidone Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Ziprasidone Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ziprasidone Drugs Major Company Production Sites and Headquarters Table 35. Global Ziprasidone Drugs Company, Product Type & Application Table 36. Global Ziprasidone Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ziprasidone Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ziprasidone Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ziprasidone Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Ziprasidone Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ziprasidone Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ziprasidone Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Ziprasidone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Ziprasidone Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Ziprasidone Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ziprasidone Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ziprasidone Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Ziprasidone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Ziprasidone Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ziprasidone Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Ziprasidone Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ziprasidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ziprasidone Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Ziprasidone Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Ziprasidone Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Ziprasidone Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ziprasidone Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ziprasidone Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Ziprasidone Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Ziprasidone Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Ziprasidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ziprasidone Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Ziprasidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ziprasidone Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Ziprasidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ziprasidone Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Ziprasidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ziprasidone Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Ziprasidone Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Apotex Company Information Table 72. Apotex Business Overview Table 73. Apotex Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Apotex Ziprasidone Drugs Product Portfolio Table 75. Apotex Recent Development Table 76. Aurobindo Pharma Company Information Table 77. Aurobindo Pharma Business Overview Table 78. Aurobindo Pharma Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Aurobindo Pharma Ziprasidone Drugs Product Portfolio Table 80. Aurobindo Pharma Recent Development Table 81. Chartwell Company Information Table 82. Chartwell Business Overview Table 83. Chartwell Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Chartwell Ziprasidone Drugs Product Portfolio Table 85. Chartwell Recent Development Table 86. Dr. Reddy's Laboratories Company Information Table 87. Dr. Reddy's Laboratories Business Overview Table 88. Dr. Reddy's Laboratories Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Dr. Reddy's Laboratories Ziprasidone Drugs Product Portfolio Table 90. Dr. Reddy's Laboratories Recent Development Table 91. Gland Pharma Company Information Table 92. Gland Pharma Business Overview Table 93. Gland Pharma Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Gland Pharma Ziprasidone Drugs Product Portfolio Table 95. Gland Pharma Recent Development Table 96. Lupin Company Information Table 97. Lupin Business Overview Table 98. Lupin Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Lupin Ziprasidone Drugs Product Portfolio Table 100. Lupin Recent Development Table 101. Viatris Company Information Table 102. Viatris Business Overview Table 103. Viatris Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Viatris Ziprasidone Drugs Product Portfolio Table 105. Viatris Recent Development Table 106. Zydus Company Information Table 107. Zydus Business Overview Table 108. Zydus Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Zydus Ziprasidone Drugs Product Portfolio Table 110. Zydus Recent Development Table 111. Pfizer Company Information Table 112. Pfizer Business Overview Table 113. Pfizer Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Pfizer Ziprasidone Drugs Product Portfolio Table 115. Pfizer Recent Development Table 116. Jiangsu Nhwa Pharmaceutical Company Information Table 117. Jiangsu Nhwa Pharmaceutical Business Overview Table 118. Jiangsu Nhwa Pharmaceutical Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Jiangsu Nhwa Pharmaceutical Ziprasidone Drugs Product Portfolio Table 120. Jiangsu Nhwa Pharmaceutical Recent Development Table 121. Sandoz Company Information Table 122. Sandoz Business Overview Table 123. Sandoz Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Sandoz Ziprasidone Drugs Product Portfolio Table 125. Sandoz Recent Development Table 126. Chongqing Shenghuaxi Pharmaceutical Company Information Table 127. Chongqing Shenghuaxi Pharmaceutical Business Overview Table 128. Chongqing Shenghuaxi Pharmaceutical Ziprasidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Chongqing Shenghuaxi Pharmaceutical Ziprasidone Drugs Product Portfolio Table 130. Chongqing Shenghuaxi Pharmaceutical Recent Development Table 131. North America Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Ziprasidone Drugs Sales by Country (2021-2026) & (K Units) Table 133. North America Ziprasidone Drugs Sales Market Share by Country (2021-2026) Table 134. North America Ziprasidone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Ziprasidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. North America Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Ziprasidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Ziprasidone Drugs Market Share by Country (2021-2026) Table 139. North America Ziprasidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Ziprasidone Drugs Market Share Forecast by Country (2027-2032) Table 141. Europe Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Ziprasidone Drugs Sales by Country (2021-2026) & (K Units) Table 143. Europe Ziprasidone Drugs Sales Market Share by Country (2021-2026) Table 144. Europe Ziprasidone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Ziprasidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Ziprasidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Ziprasidone Drugs Market Share by Country (2021-2026) Table 149. Europe Ziprasidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Ziprasidone Drugs Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Ziprasidone Drugs Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Ziprasidone Drugs Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Ziprasidone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Ziprasidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Ziprasidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Ziprasidone Drugs Market Share by Country (2021-2026) Table 159. Asia-Pacific Ziprasidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Ziprasidone Drugs Market Share Forecast by Country (2027-2032) Table 161. Latin America Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Ziprasidone Drugs Sales by Country (2021-2026) & (K Units) Table 163. Latin America Ziprasidone Drugs Sales Market Share by Country (2021-2026) Table 164. Latin America Ziprasidone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Ziprasidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Ziprasidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Ziprasidone Drugs Market Share by Country (2021-2026) Table 169. Latin America Ziprasidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Ziprasidone Drugs Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Ziprasidone Drugs Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Ziprasidone Drugs Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Ziprasidone Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Ziprasidone Drugs Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Ziprasidone Drugs Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Ziprasidone Drugs Market Share by Country (2021-2026) Table 179. Middle East and Africa Ziprasidone Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Ziprasidone Drugs Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Ziprasidone Drugs Distributors List Table 184. Ziprasidone Drugs Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Ziprasidone Drugs Image Figure 2. Global Ziprasidone Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ziprasidone Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Ziprasidone Drugs Sales (2021-2032) & (K Units) Figure 5. Ziprasidone Hydrochloride Image Figure 6. Global Ziprasidone Hydrochloride Sales YoY Growth (2021-2032) & (K Units) Figure 7. Ziprasidone Mesylate Image Figure 8. Global Ziprasidone Mesylate Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Ziprasidone Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ziprasidone Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Ziprasidone Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Ziprasidone Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Ziprasidone Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ziprasidone Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ziprasidone Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ziprasidone Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ziprasidone Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ziprasidone Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ziprasidone Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ziprasidone Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ziprasidone Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Ziprasidone Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Ziprasidone Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Ziprasidone Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Ziprasidone Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Ziprasidone Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Ziprasidone Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Ziprasidone Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Ziprasidone Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Ziprasidone Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Ziprasidone Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Ziprasidone Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Ziprasidone Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Ziprasidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Ziprasidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Ziprasidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Ziprasidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ziprasidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Ziprasidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ziprasidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Ziprasidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ziprasidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Ziprasidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ziprasidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Ziprasidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ziprasidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Ziprasidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ziprasidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Ziprasidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ziprasidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Ziprasidone Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ziprasidone Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Ziprasidone Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Ziprasidone Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Ziprasidone Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Ziprasidone Hydrochloride
  • Ziprasidone Mesylate
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Apotex
  • Aurobindo Pharma
  • Chartwell
  • Dr. Reddy's Laboratories
  • Gland Pharma
  • Lupin
  • Viatris
  • Zydus
  • Pfizer
  • Jiangsu Nhwa Pharmaceutical
  • Sandoz
  • Chongqing Shenghuaxi Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ziprasidone Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ziprasidone Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ziprasidone Drugs Market by Type
  6. 1.3.1 Ziprasidone Hydrochloride
  7. 1.3.2 Ziprasidone Mesylate
  8. 1.4 Global Ziprasidone Drugs Market Size by Type
  9. 1.4.1 Global Ziprasidone Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ziprasidone Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ziprasidone Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ziprasidone Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ziprasidone Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ziprasidone Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ziprasidone Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ziprasidone Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ziprasidone Drugs Industry Trends
  2. 2.2 Ziprasidone Drugs Industry Drivers
  3. 2.3 Ziprasidone Drugs Industry Opportunities and Challenges
  4. 2.4 Ziprasidone Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ziprasidone Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Ziprasidone Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Ziprasidone Drugs Price (2021-2026)
  4. 3.4 Global Ziprasidone Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ziprasidone Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Ziprasidone Drugs Company, Product Type & Application
  7. 3.7 Global Ziprasidone Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ziprasidone Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ziprasidone Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ziprasidone Drugs Tier 1, Tier 2, and Tier 3
4 Ziprasidone Drugs Regional Status and Outlook
  1. 4.1 Global Ziprasidone Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ziprasidone Drugs Historic Market Size by Region
  3. 4.2.1 Global Ziprasidone Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ziprasidone Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ziprasidone Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ziprasidone Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Ziprasidone Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ziprasidone Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ziprasidone Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ziprasidone Drugs by Application
  1. 5.1 Ziprasidone Drugs Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Ziprasidone Drugs Market Size by Application
  6. 5.2.1 Global Ziprasidone Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ziprasidone Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ziprasidone Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ziprasidone Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ziprasidone Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ziprasidone Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ziprasidone Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ziprasidone Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Apotex
  2. 6.1.1 Apotex Company Information
  3. 6.1.2 Apotex Business Overview
  4. 6.1.3 Apotex Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Apotex Ziprasidone Drugs Product Portfolio
  6. 6.1.5 Apotex Recent Developments
  7. 6.2 Aurobindo Pharma
  8. 6.2.1 Aurobindo Pharma Company Information
  9. 6.2.2 Aurobindo Pharma Business Overview
  10. 6.2.3 Aurobindo Pharma Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aurobindo Pharma Ziprasidone Drugs Product Portfolio
  12. 6.2.5 Aurobindo Pharma Recent Developments
  13. 6.3 Chartwell
  14. 6.3.1 Chartwell Company Information
  15. 6.3.2 Chartwell Business Overview
  16. 6.3.3 Chartwell Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chartwell Ziprasidone Drugs Product Portfolio
  18. 6.3.5 Chartwell Recent Developments
  19. 6.4 Dr. Reddy's Laboratories
  20. 6.4.1 Dr. Reddy's Laboratories Company Information
  21. 6.4.2 Dr. Reddy's Laboratories Business Overview
  22. 6.4.3 Dr. Reddy's Laboratories Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dr. Reddy's Laboratories Ziprasidone Drugs Product Portfolio
  24. 6.4.5 Dr. Reddy's Laboratories Recent Developments
  25. 6.5 Gland Pharma
  26. 6.5.1 Gland Pharma Company Information
  27. 6.5.2 Gland Pharma Business Overview
  28. 6.5.3 Gland Pharma Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gland Pharma Ziprasidone Drugs Product Portfolio
  30. 6.5.5 Gland Pharma Recent Developments
  31. 6.6 Lupin
  32. 6.6.1 Lupin Company Information
  33. 6.6.2 Lupin Business Overview
  34. 6.6.3 Lupin Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lupin Ziprasidone Drugs Product Portfolio
  36. 6.6.5 Lupin Recent Developments
  37. 6.7 Viatris
  38. 6.7.1 Viatris Company Information
  39. 6.7.2 Viatris Business Overview
  40. 6.7.3 Viatris Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Viatris Ziprasidone Drugs Product Portfolio
  42. 6.7.5 Viatris Recent Developments
  43. 6.8 Zydus
  44. 6.8.1 Zydus Company Information
  45. 6.8.2 Zydus Business Overview
  46. 6.8.3 Zydus Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zydus Ziprasidone Drugs Product Portfolio
  48. 6.8.5 Zydus Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Ziprasidone Drugs Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Jiangsu Nhwa Pharmaceutical
  56. 6.10.1 Jiangsu Nhwa Pharmaceutical Company Information
  57. 6.10.2 Jiangsu Nhwa Pharmaceutical Business Overview
  58. 6.10.3 Jiangsu Nhwa Pharmaceutical Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jiangsu Nhwa Pharmaceutical Ziprasidone Drugs Product Portfolio
  60. 6.10.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  61. 6.11 Sandoz
  62. 6.11.1 Sandoz Company Information
  63. 6.11.2 Sandoz Business Overview
  64. 6.11.3 Sandoz Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sandoz Ziprasidone Drugs Product Portfolio
  66. 6.11.5 Sandoz Recent Developments
  67. 6.12 Chongqing Shenghuaxi Pharmaceutical
  68. 6.12.1 Chongqing Shenghuaxi Pharmaceutical Company Information
  69. 6.12.2 Chongqing Shenghuaxi Pharmaceutical Business Overview
  70. 6.12.3 Chongqing Shenghuaxi Pharmaceutical Ziprasidone Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chongqing Shenghuaxi Pharmaceutical Ziprasidone Drugs Product Portfolio
  72. 6.12.5 Chongqing Shenghuaxi Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Ziprasidone Drugs Sales by Country
  2. 7.1.1 North America Ziprasidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ziprasidone Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Ziprasidone Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ziprasidone Drugs Market Size by Country
  6. 7.2.1 North America Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ziprasidone Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Ziprasidone Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ziprasidone Drugs Sales by Country
  2. 8.1.1 Europe Ziprasidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ziprasidone Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Ziprasidone Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ziprasidone Drugs Market Size by Country
  6. 8.2.1 Europe Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ziprasidone Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ziprasidone Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ziprasidone Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Ziprasidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ziprasidone Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ziprasidone Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ziprasidone Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ziprasidone Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ziprasidone Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ziprasidone Drugs Sales by Country
  2. 10.1.1 South America Ziprasidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ziprasidone Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Ziprasidone Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ziprasidone Drugs Market Size by Country
  6. 10.2.1 South America Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ziprasidone Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Ziprasidone Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ziprasidone Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Ziprasidone Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ziprasidone Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ziprasidone Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ziprasidone Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Ziprasidone Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ziprasidone Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ziprasidone Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ziprasidone Drugs Value Chain Analysis
  2. 12.1.1 Ziprasidone Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ziprasidone Drugs Production Mode & Process
  7. 12.2 Ziprasidone Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ziprasidone Drugs Distributors
  10. 12.2.3 Ziprasidone Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst